Cellectar Biosciences, Inc. Proceeds from Issuance of Warrants
Cellectar Biosciences, Inc. (CLRB) reported Proceeds from Issuance of Warrants of $348.64 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2023-11-13
- Cellectar Biosciences, Inc. proceeds from issuance of warrants for the quarter ending 2023-09-30 was $348.64K.
- Cellectar Biosciences, Inc. proceeds from issuance of warrants for the quarter ending 2023-06-30 was $0.00.
- Cellectar Biosciences, Inc. proceeds from issuance of warrants for the quarter ending 2023-03-31 was $3.00.
- Cellectar Biosciences, Inc. proceeds from issuance of warrants for the quarter ending 2021-09-30 was $0.00.
- Cellectar Biosciences, Inc. proceeds from issuance of warrants for fiscal 2017 was $2.96M, a 354.11% increase from fiscal 2016.
- Cellectar Biosciences, Inc. proceeds from issuance of warrants for fiscal 2016 was $652.54K.
- Cellectar Biosciences, Inc. proceeds from issuance of warrants for fiscal 2015 was $0.00.
| Period end | Proceeds from Issuance of Warrants | Proceeds from Issuance of Warrants 1 month | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2023-09-30 | $348.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $348.64K derived: sum of 2 quarters · filed 2023-11-13 | $348.64K 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.00 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $3.00 10-Q · filed 2023-05-04 | |||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $1.21M 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $1.21M 10-Q · filed 2022-08-05 | ||||
| 2021-03-31 | $1.21M 10-Q · filed 2022-05-10 | |||||
| 2020-09-30 | $31.70K 10-Q · filed 2021-11-08 | |||||
| 2019-05-20 | $4.00M 10-K · filed 2021-03-02 | $4.00M 10-Q · filed 2020-11-09 | ||||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-11 | $0.00 derived: sum of 2 quarters · filed 2018-05-11 | $22.50K derived: sum of 3 quarters · filed 2018-05-11 | $28.50K derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $22.50K derived: sum of 2 quarters · filed 2018-03-21 | $28.50K derived: sum of 3 quarters · filed 2018-03-21 | $2.96M 10-K · filed 2018-03-21 | ||
| 2017-09-30 | $22.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $28.50K derived: sum of 2 quarters · filed 2017-11-09 | $2.96M 10-Q · filed 2017-11-09 | $2.96M derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2017-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $2.94M 10-Q · filed 2017-08-14 | $2.94M derived: sum of 3 quarters · filed 2018-05-11 | $2.94M derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2017-03-31 | $2.93M 10-Q · filed 2018-05-11 | $2.93M derived: sum of 2 quarters · filed 2018-05-11 | $2.93M derived: sum of 3 quarters · filed 2018-05-11 | $3.59M derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2016-12-31 | $21.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $21.00 derived: sum of 2 quarters · filed 2018-03-21 | $652.54K derived: sum of 3 quarters · filed 2018-03-21 | $652.54K 10-K · filed 2018-03-21 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $652.52K derived: sum of 2 quarters · filed 2017-11-09 | $652.52K 10-Q · filed 2017-11-09 | $652.52K derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $652.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $652.52K 10-Q · filed 2017-08-14 | $652.52K derived: sum of 3 quarters · filed 2017-08-14 | $652.52K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-11 | $0.00 derived: sum of 2 quarters · filed 2017-05-11 | $0.00 derived: sum of 3 quarters · filed 2017-05-11 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | ||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-11 | |||||
| 2012-11-30 | $2.00M 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |